Halloran is heading to SCOPE Summit 2024

Visit us at Booth #202

About Halloran

Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, technology, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors. Our consultants are subject matter experts who deliver a tailored approach to each engagement, propelling our clients to their next inflection point. We connect clients with our trusted industry partners to drive operational excellence and innovation throughout their organizations. We aim to support our clients and the patients they serve.

Meet the Halloran SCOPE Team

Sheila Gwizdak Head of Consulting (1)
HCG Team

Speaker Highlight

scope social

Sheila Gwizdak, Head of Consulting

Excellence Unveiled: Elevating Clinical Trials through
Cutting-Edge Quality and Monitoring Strategies

Lunch Session | Monday, February 12 | 12:55pm

This session explores the dynamic landscape of clinical trials, focusing on innovative quality assurance and monitoring techniques. Attendees will learn their pivotal role in enhancing trial efficiency, reliability, and participant safety. The session will highlight the synergies between quality strategies, and monitoring protocols using evolving methodologies, technologies, and regulatory frameworks. By leveraging analytics and real-time tools, we will navigate their transformative potential to advance the pursuit of excellence in clinical trials.

Read Our Insights


Navigating Clinical Trial Leadership Turnover: Halloran’s Five-Step Process

Clinical Trial Leaders are critical to the success of a clinical trial. But what happens when you lose a person filling one of these key roles?

Read It Here ➞


Operational Disruption: Assuring Clinical Data Integrity

Clinical trial sponsors are responsible for all their regulated data, including where it resides and the processes and controls in place to protect that data. What do you do when you encounter disruptions midstream?

Read It Here ➞


Patient Diversity and Engagement Strategies Propelled by FDORA – Are You Prepared?

We believe clinical trial design should not be developed without critical feedback from patients. Why? Hear from our experts.

Watch It Here ➞